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Background: A novel concept of peri-stent contrast staining (PSS) is an angiographical finding that contrast medium stains outside the stent and 
is thought to be one of the risk factors for very late stent thrombosis (VLST). Stent fracture (SF) is also thought to be one of the risk factor for VLST. 
Although preceding angiographical findings including PSS and SF before VLST occurrence might indicate the predisposing condition of VLST, there is 
no study about the association between them.
Methods: We retrospectively examined whether PSS and SF had occurred in patients with VLST after sirolimus eluting stent (SES) implantation 
who had undergone serial coronary angiography (CAG) before VLST occurrence. PSS is defined as vessel enlargementover 20% of stent diameter with 
contrast medium staining outside the stent. VLST is defined as the occurrence of acute myocardial infarction due to stent thrombosis confirmed with 
CAG at least one year after stent implantation. Stent fracture is defined as the separation of stent segments or stent struts.
Results:Between June 2009 and September 2010, we confirmed 17 patients with VLST after SES implantation. PSS was found in 5 of the 17 patients 
(29.4%). SF was found in 8 of 17 patients (38.9%). Both were found in 3 of the 17 patients (17.6%). The progression of PSS was confirmed with 
serial CAG in 3 of the 5 patients (60%) with VLST and PSS.
Conclusions: PSS and SF might be associated with the occurrence of VLST. Serial follow-up CAG might be useful to identify the patients at high risk 
for VLST. 
